<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Nishiyama K</submitter><funding>Takeda Science Foundation to Proteo-Science Center</funding><funding>JSPS KAKENHI</funding><funding>SPS KAKENHI</funding><funding>Japan Foundation for Applied Enzymology, Research Grant of the Princess Takamatsu Cancer Research Fund, The Research Foundation for Pharmaceutical Sciences</funding><pagination>e202101095</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8321701</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>4(9)</volume><pubmed_abstract>Epidermal growth factor receptor (EGFR) and human EGFR 2 (HER2) phosphorylation drives HER2-positive breast cancer cell proliferation. Enforced activation of phosphatases for those receptors could be a therapeutic option for HER2-positive breast cancers. Here, we report that degradation of an endosomal small GTPase, RhoB, by the ubiquitin ligase complex cullin-3 (CUL3)/KCTD10 is essential for both EGFR and HER2 phosphorylation in HER2-positive breast cancer cells. Using human protein arrays produced in a wheat cell-free protein synthesis system, RhoB-GTP, and protein tyrosine phosphatase receptor type H (PTPRH) were identified as interacting proteins of connector enhancer of kinase suppressor of Ras1 (CNKSR1). Mechanistically, constitutive degradation of RhoB, which is mediated by the CUL3</pubmed_abstract><journal>Life science alliance</journal><pubmed_title>CNKSR1 serves as a scaffold to activate an EGFR phosphatase via exclusive interaction with RhoB-GTP.</pubmed_title><pmcid>PMC8321701</pmcid><funding_grant_id>19K18030</funding_grant_id><funding_grant_id>19K18029</funding_grant_id><funding_grant_id>21H02763</funding_grant_id><pubmed_authors>Higashiyama S</pubmed_authors><pubmed_authors>Nakayama J</pubmed_authors><pubmed_authors>Takada Y</pubmed_authors><pubmed_authors>Kiyoi T</pubmed_authors><pubmed_authors>Nakagita T</pubmed_authors><pubmed_authors>Nishiyama K</pubmed_authors><pubmed_authors>Murakami A</pubmed_authors><pubmed_authors>Kamei Y</pubmed_authors><pubmed_authors>Chosei M</pubmed_authors><pubmed_authors>Maekawa M</pubmed_authors><pubmed_authors>Takeda H</pubmed_authors></additional><is_claimable>false</is_claimable><name>CNKSR1 serves as a scaffold to activate an EGFR phosphatase via exclusive interaction with RhoB-GTP.</name><description>Epidermal growth factor receptor (EGFR) and human EGFR 2 (HER2) phosphorylation drives HER2-positive breast cancer cell proliferation. Enforced activation of phosphatases for those receptors could be a therapeutic option for HER2-positive breast cancers. Here, we report that degradation of an endosomal small GTPase, RhoB, by the ubiquitin ligase complex cullin-3 (CUL3)/KCTD10 is essential for both EGFR and HER2 phosphorylation in HER2-positive breast cancer cells. Using human protein arrays produced in a wheat cell-free protein synthesis system, RhoB-GTP, and protein tyrosine phosphatase receptor type H (PTPRH) were identified as interacting proteins of connector enhancer of kinase suppressor of Ras1 (CNKSR1). Mechanistically, constitutive degradation of RhoB, which is mediated by the CUL3</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2026-05-08T13:04:32.231Z</modification><creation>2022-02-11T04:14:29.304Z</creation></dates><accession>S-EPMC8321701</accession><cross_references><pubmed>34187934</pubmed><doi>10.26508/lsa.202101095</doi></cross_references></HashMap>